TNFRSF19 and Alzheimer disease: Five out of six were downregulated in AD, and one, the LINGO1-TROY-NgR complex, which was previously suggested to be important for modulating glial-neuronal interactions in demyelinating lesions, was upregulated in AD (Satoh et al., 2007).